NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2025
Voltar para busca
Dado oficial do USPTO
LEVEL-UP NORMALIZATION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LEVEL-UP NORMALIZATION
ST13
US500000098190758Classe
9, 10, 42, 44
Pedido
98190758
Registro
8055269
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
09/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 42, 44
Data de depósito
21/09/2023
Data de registro
09/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
09/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
EDINBURGH, EH4 2HS, GB
Examinador
OJEYEMI, ASHLEY CHRISTINE
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Wobble Genomics Limited
Representantes
M. Scott Alprin ALPRIN LAW OFFICES, P.C.
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer softwarelaboratory apparatusinstrumentsequipment and devices for sequencingsamplingtestingdiscoveryintegrationnormalisationequalisationmeasuring and detection of DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; Downloadable computer softwarelaboratory apparatusinstrumentsequipment and devices for sequencingsamplingtestingdiscoveryintegrationnormalisationequalisationmeasuring and detection of genetic datainformation and materials; Downloadable computer softwarelaboratory apparatusinstrumentsequipment and devices for sequencingsamplingtestingdiscoveryintegrationnormalisationequalisationmeasuring and detection of biological datainformation and materials; laboratory equipmentapparatusdevicessystems and downloadable software for DNARNA and polynucleic acid sample sequencingsamplingtestingdiscoveryintegrationnormalisationequalisationmeasuring and detection; laboratory equipmentapparatusdevicessystems and downloadable software for preparationpurificationamplificationlabelling and analysis of biological samples and materials; laboratory equipmentapparatusdevicessystems and downloadable softwarenucleic acid sequencers and synthesizersinstruments for preparation of nucleic acid samples in the form of small sample containersfor testing nucleic acidprotein sequencersgenetic analysersseparation apparatuspre-packed columns for use in separation and purificationnucleic acid purification apparatusnucleic acid quantitation apparatusthermal cyclerscytometry apparatusprotein and peptide synthesizersmass spectrometers and chromatographs; laboratory equipment for identification and detection of the presence of biologicals or chemicals in a sample; laboratory devices for analysis of genome information; biotechnological apparatuslaboratory apparatus and instruments for extracting DNAnot for medical purposes; nucleic acid sequencers for scientific purposes; microbiological analysisdetectionscreening and testing apparatuslaboratory apparatus and computer systems for use in protein purification; apparatus and devices for carrying out diagnostic testsdiagnostic apparatus for research laboratory use for DNA analysis; laboratory apparatusdevices and instruments for identifyingmeasuringanalysingsequencing or synthesising small moleculesgenomesDNARNA or other nucleic acidsproteinspeptideshormonesmetabolic markers and sugars; apparatus and devices for use in DNARNAprotein and polynucleic acid sequencing
Classe 10
Medicalveterinarypharmaceutical and clinical diagnostic apparatus for sequencingsamplingtestingdiscoveryintegrationnormalisationequalisationmeasuring and detection of DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; medicalveterinarypharmaceutical and clinical diagnostic devicesapparatustools and instruments for testing of DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; biological and microbiological analysisdetectionscreening and testing apparatus for medical purposessurgical devices that facilitate the identification or separation of biologic tissues; medicalveterinarypharmaceutical and clinical diagnostic apparatus for detectingidentifyingtesting and analysing DNARNAproteinspeptideshormonesmetabolic markers and sugars; medicalveterinarypharmaceutical and clinical diagnostic apparatusinstrumentsequipment and devices for use in detection of proteinspeptidessugars or metabolites; medicalveterinarypharmaceutical and clinical diagnostic apparatus and instruments for biologicalbacteriologicalchemicalbiochemical and molecular analysis; medicalveterinarypharmaceutical and clinical diagnostic apparatusdevices and instruments for identifyingmeasuringanalysingsequencing or synthesising small moleculesgenomesDNARNA or other nucleic acidsproteinspeptideshormonesmetabolic markers and sugars; medical diagnostic and testing apparatus for testing of DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants
Classe 42
Researchdevelopmentanalysis and testing services relating to DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; scientific research relating to genetics; genetic researchtestingscreeninganalysis and engineering; biological and biotechnological research and analysis; biological laboratory services; preparation of biological samples for testingresearch and analysis purposes; medicalclinical and biological research and development services; research and development in the field of diagnostic preparations; provision of information and data relating to medical research and development; conducting clinical trials; researchdevelopment and analysis in the field of molecular biology; blood analysis services for scientific and research purposes; laboratory servicesservices for research laboratory analysis of DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; laboratory testing servicesgenetic testing for scientific research purposes; structural and functional analysis of genomes; biologicalmicrobiological and viral screening and testing services for scientific research purposes; researchdesign and development relating to biological and microbiological tests and testing apparatus; diagnostic testing relating to human or animal health for scientific research purposes; analysis and testing of physiological samples for scientific research purposes; medicalscientific and technical research services relating to DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; biochemical research and development; chemical analysis for scientific research purposes; pharmaceutical research and development; medicalclinicalbiologicalscientific and technological researchdevelopmentanalysis and testing services for scientific research purposes; researchdevelopmentanalysis and testing services relating to genome sequencing for scientific research purposes; informationadvisory and consultancy services relating to all the aforesaid services
Classe 44
Medical sequencingsamplingtestingdiscoveryintegrationnormalisationequalisationmeasuring and detection services relating to DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; animal tissue bank services; cryotherapy services; collection and preservation of animal genetic materials; revival and restoration of animal genetic materials; veterinary services relating to testing of DNARNAnucleic acidnucleic acid biomarkersnovel genesisoformsproteins and protein variants; veterinary services relating to the treatment and processing of stem cells; genetic testing of animals for diagnostic and treatment purposes; medical diagnostic services; medical screening and testing services; medical monitoring and reporting services; optical imaging for medical diagnostic use; medical testing for diagnostic or treatment purposes; medical data services; DNA and RNA testingscreeningextraction and purification services for medical purposes; medical evaluation services; medical screeningtestingmonitoringreporting and analysis services relating to genome sequencing; medical services in the nature of amplifyinglabellingdetectinganalysing and sequencing nucleic acids; medical screeningtestingmonitoringreporting and analysis services relating to cellstissuesgene expressionsgene and genome sequencesgenome annotationgenome mappinggenome interaction and annotationall for medical purposes; informationadvisory and consultancy services relating to all the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/10/2025
PUBO
PUBLISHED FOR OPPOSITION
21/10/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/10/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
19/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
28/07/2025
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
27/01/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
30/04/2024
GNSL
LETTER OF SUSPENSION E-MAILED
30/04/2024
CNSL
SUSPENSION LETTER WRITTEN
30/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/01/2024
GNRT
NON-FINAL ACTION E-MAILED
31/01/2024
CNRT
NON-FINAL ACTION WRITTEN
31/01/2024
DOCK
ASSIGNED TO EXAMINER
22/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2023
NWAP
NEW APPLICATION ENTERED
25/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LEVEL-UP NORMALIZATION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.